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Abstract  
Background:  Parasternal intercostal muscle electromyography (EMGpara) represents a 
novel tool to assess respiratory load when volitional techniques are not possible.  This 
study examined the application of EMGpara in healthy, wheezy and critically ill children. 
Methods:  Surface EMGpara was measured during tidal breathing in 92 healthy children, 
20 wheezy preschool children (with measurements repeated following bronchodilator), 
and 25 mechanically ventilated children during supported ventilation and on CPAP.   
Results:  EMGpara was related to age, height and weight in the healthy group (r=-0.623, 
-0.625 -0.641 respectively, all p<0.0001).  An age-based equation for predicted EMGpara 
was developed and patient data expressed as z-scores.  EMGpara was higher in wheezy 
children pre-bronchodilator than healthy controls (median (IQR) z-score 0.53 (0.07 – 
1.94), p=0.0073), falling to levels not different to healthy children post-bronchodilator (-
0.08 (-0.50 – 1.00)).  In the critically ill children, EMGpara was higher (p<0.0001) than in 
healthy subjects during both mechanical ventilation (median (IQR) z-score 1.14 (0.33 – 
1.93)) and while on CPAP (1.88 (0.91 – 3.03)). 
Conclusions:  EMGpara is feasible in children and infants both in health and disease, is 
raised in those with elevated respiratory load, and is responsive to clinical interventions.  
EMGpara represents a potential method to assess respiratory status in patients 
conventionally challenging to assess. 
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Introduction 
Accurate assessment of respiratory function is crucial for optimal disease management 
in a range of settings, and volitional testing methods are frequently used.  Certain 
patient populations such as young children and those receiving intensive care are, 
however, unable to comply with such testing.  Assessment of such patient groups 
therefore revolves primarily around clinical examination and basic physiological 
parameters.  Clinical examination, while essential in the evaluation of any patient, often 
relates poorly to objective assessment of disease state and clinical outcome (1-3) and 
should therefore be supplemented with tools to objectively quantify the severity of 
respiratory disease.  The development of effort-independent markers of respiratory 
function is therefore of substantial importance(4).   
A number of non-volitional techniques have been developed to assess various aspects of 
respiratory function, such as the forced oscillation technique (FOT), plethysmographic 
airways resistance, lung clearance index (LCI) and respiratory interrupter resistance 
(Rint)(4).  Although feasible in older children and adults, these techniques still require 
passive cooperation from the subject in order to maintain steady tidal breathing with a 
leak-free seal around the mouthpiece or mask.  Successful measurements may be 
challenging in younger children, and may require sedation for use in infants.  Many of 
these techniques are also unsuitable for use in critically ill populations. 
Ventilation is dependent on the load placed on the respiratory system, the force 
generating capacity of the respiratory muscles, and the neural output from brainstem 
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respiratory centres (neural respiratory drive (NRD)).  NRD increases in parallel with 
respiratory load in order to maintain adequate levels of ventilation for blood gas 
homeostasis(5).  NRD can be recorded from the electromyogram (EMG) of selected 
important respiratory muscles.  While diaphragm EMG (EMGdi) provides a sensitive 
measure of NRD which reflects the load on the respiratory muscles(6), obtaining 
uncontaminated signals requires the passage of an esophageal catheter, making the 
technique unsuited to routine clinical use, particularly in pediatrics.  The parasternal 
intercostal muscles are obligate inspiratory muscles, recruited in tandem with the 
diaphragm(7), whose anatomical location results in them being well suited to the 
measurement of NRD.  EMGpara therefore provides a non-invasive measure of NRD that 
potentially could be used to assess lung disease severity and guide patient management 
in children with a range of conditions.  We have previously demonstrated that EMGpara 
is responsive to changes in respiratory load in healthy adult subjects (8) and provides a 
non-invasive marker of neural drive that reflects disease severity and exercise-induced 
breathlessness in adult patients with cystic fibrosis (9). 
The aims of this study were, therefore, to examine the feasibility of measuring EMGpara 
in a range of pediatric populations, to explore the factors influencing EMGpara in 
healthy children of a range of ages, to compare EMGpara between healthy children and 
those with respiratory disease, and to examine the EMGpara response to increases and 
decreases in respiratory load.  
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Some of these data have previously been presented in abstract form, in the context of 
interim analyses of each cohort (10-12). 
Results 
In total, 92 healthy children, 20 children with preschool wheeze and 25 children 
receiving intensive care were studied.  Subject characteristics are presented in Table 1, 
with additional data for the PICU cohort presented in Table 2.  Example EMGpara traces 
before and after bronchodilator administration are shown in Figure 1. 
Healthy children 
Median (IQR) EMGpara in the cohort of 92 healthy children was 4.91 (3.67 – 6.59)µV.  
There were more female (n=57) than male (n=35) subjects within the healthy cohort, 
although height, weight, age and BMI were not significantly different between sexes.  
There was no significant difference in median (IQR) EMGpara between male and female 
healthy children (5.61 (3.64 – 8.48)µV versus 4.76 (3.70 – 6.26)µV, p=0.189). 
Of the 92 healthy children, 56 were able to reliably perform maximal inspiratory efforts 
to TLC.  Median (IQR) EMGpara%max for this cohort of 56 children was 6.80 (5.06 – 
10.16)%.  The corresponding median (IQR) EMGpara for the same 56 children was 4.46 
(3.56 – 6.04)µV.  The median (IQR) age of those children who could reliably perform 
such maneuvers was significantly higher than those who could not (11.07 (7.85 – 14.16) 
versus 5.37 (2.65 – 13.53) years, p=0.0112). 
Ac
ce
pte
d m
an
us
cri
pt
 © 2016 International Pediatric Research Foundation, Inc. All rights reserved 
ACCEPTED ARTICLE PREVIEW 
In the cohort as a whole, significant negative correlations were found between EMGpara 
and age (r=-0.623), weight (r=-0.641) and height (r=-0.625, all p<0.0001, Figure 2).  
Excluding those children who were unable to perform maximal inspiratory efforts led to 
a small reduction in the strength of these relationships but they remained highly 
significant (r=-0.530, -0.599 and -0.555 respectively, all p<0.0001).  In contrast, no 
significant relationships were observed between EMGpara%max and age, weight or 
height (all p>0.2).  No significant relationships were seen between EMGpara recorded 
during the maximal inspiratory maneuver and age or height, although there was a weak 
correlation between maxEMGpara and weight (r=-0.332, p=0.013).  Application of the 
Wald-Wolfowitz runs test indicated that there was no significant deviation from linearity 
in any of the above relationships, and that the data were therefore best suited to linear 
rather than curvilinear models. 
As a non-normal distribution was observed in both the EMGpara data and the residuals 
plot, logarithmic transformation of the EMGpara values was performed to allow the 
assumptions of linear regression to be met.  Age, height and weight were all strongly 
colinear and therefore were not considered suitable as independent predictors of 
logEMGpara.  Age demonstrated the best regression model fit (R
2
=0.376, compared to 
R
2
=0.348 for logEMGpara versus height and R
2
=0.332 for logEMGpara versus weight), 
therefore predicted logEMGpara was derived from age using the equation: 
Predicted logEMGpara = −0.02347 × age + 0.9332  
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The 95% confidence intervals for the regression coefficient were -0.0298 to -0.0171, and 
for the y-intercept 0.866 to 1.001.   
Comparison to patient populations and response to change 
Wheezy preschool children: 
Median (IQR) EMGpara at baseline (prior to bronchodilator administration) in the 20 
children with preschool wheeze was 8.20 (7.01 – 13.17)µV.  This corresponded to a 
median (IQR) logEMGpara z-score of 0.53 (0.07 – 1.94).  Six of the twenty children (30%) 
demonstrated abnormally elevated EMGpara, defined as a logEMGpara greater than 
1.645 z-scores above the predicted logEMGpara derived from the healthy cohort.  None 
of the wheezy children could reliably perform maximal inspiratory maneuvers. 
Median (IQR) EMGpara fell significantly following administration of salbutamol to 6.98 
(6.01 – 10.48)µV (p=0.0037).  The post-bronchodilator value corresponded to a median 
(IQR) logEMGpara z-score of -0.08 (-0.50 – 1.00).  Only three children (15%) 
demonstrated elevated EMGpara post-salbutamol, all of whom had elevated 
logEMGpara at baseline.  logEMGpara was higher in wheezy children than predicted at 
baseline (p=0.0073), but not post-bronchodilator. 
The within-subject inter-minute coefficient of variation was 13.4% in wheezy children 
and 11.2% in the healthy cohort.  Multiplying the CV from the wheezy children by 1.65 
gave a threshold for significant BD response of 22.1%.  Using this threshold, seven of the 
20 preschool wheezy children (35%) showed a significant reduction in EMGpara 
following bronchodilator administration. 
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Mechanically ventilated PICU patients: 
Comparisons were made to levels of EMGpara observed during minimally supported 
breathing while on CPAP in the PICU children as this condition best represented the 
respiratory system under load.  Median (IQR) EMGpara on CPAP was 12.7 (9.9 – 17.9)µV 
which corresponded to a median (IQR) logEMGpara z-score of 1.88 (0.91 – 3.03).  
Fourteen (56%) of the children had an elevated logEMGpara, greater than 1.645 z-scores 
above the predicted value from healthy children.  A weak inverse relationship was 
observed between age and EMGpara measured both during MV (r=-0.560, p=0.004) and 
CPAP (r=-0.402, p=0.046), reflecting the findings from the healthy cohort.  When 
receiving MV median (IQR) logEMGpara was 1.14 (0.33 – 1.93), with nine children (36%) 
demonstrating abnormally elevated EMGpara.  logEMGpara was significantly higher 
than predicted under both conditions (p<0.0001). 
Both EMGpara and NVE were significantly lower on MV compared to CPAP (Table 3).  No 
significant changes in RR, VT or respiratory duty cycle (Ti:Ttot) were observed when 
patients were switched from MV to CPAP (Table 3).  Neither EMGpara nor NVE when 
measured at baseline on MV or change in either variable when switched to CPAP were 
related to duration of MV (all r<0.26, p>0.2). 
Three children failed extubation and were subsequently reintubated.  Increased work of 
breathing with inability to maintain blood oxygenation was documented as the reason 
for reintubation in all three cases, with one child additionally experiencing pulmonary 
edema and elevated CO2 levels.  All three demonstrated elevated EMGpara both during 
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MV and while on CPAP.  Thresholds for predicting extubation outcome, together with 
sensitivity and specificity values and area under the ROC curve for each measured 
variable are shown in Table 4.  NVE during CPAP was the strongest predictor of 
extubation outcome, using a threshold of 0.43ml/kg/µV.  NVE on MV and EMGpara on 
MV or on CPAP also performed well, with existing indices demonstrating poorer 
predictive ability. 
 
Discussion 
These studies have demonstrated the feasibility of measuring EMGpara in children of a 
range of ages, both in health and disease.  The data from healthy children have shown 
important age-related changes in EMGpara and are sufficient for comparative purposes 
against the patient data acquired in the current study.  EMGpara has been shown to be 
sensitive to change in respiratory load induced by bronchodilation in the cohort of 
children with wheeze and by removal of inspiratory pressure support in critically ill 
children.  EMGpara, as a measure of NRD, therefore demonstrates potential value in the 
assessment of disease severity and physiological responses to treatment in pediatric 
respiratory and critical care, providing a valuable aid to patient management.   
A commonly reported limitation of surface EMG recordings is the inherently poor 
between-subject and between-occasion reproducibility, resulting from differences in 
body composition and electrode placement (9, 13, 14).  To overcome this, previous 
studies have expressed resting EMGpara as a percentage of that obtained during a 
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maximal maneuver (EMGpara%max).  Such an approach, however, limits the technique 
to those subjects able to reliably perform volitional efforts and renders the technique 
unsuitable for use in young children and infants, as well as patients who are unable to 
perform such manoeuvres as a result of fatigue, pain, poor comprehension or 
motivation.  In our study, the difficulties associated with acquiring reliable maximal 
EMGpara signals were highlighted by the finding that such measures could only be 
obtained in 56 of the 92 healthy subjects, and in none of the preschool children with 
wheeze.  Similarly, achieving reliable maximal inspiratory efforts is difficult in intubated, 
sedated pediatric patients, and can only be obtained by using maintained ETT 
occlusion(15).  ETT occlusion may not, however, represent a suitable method for 
obtaining maximal EMGpara as inhibition of parasternal intercostal muscle activity 
during static (isovolume) inspiratory maneuvers has been demonstrated(16).  For this 
reason, maxEMGpara was not recorded in our PICU cohort.  Our data suggest, however, 
that EMGpara recorded during tidal breathing in children provides a simple and feasible 
technique to assess NRD without the need for complex respiratory maneuvers.  Data 
regarding inter-occasion variability of the EMGpara signal would be required to facilitate 
the use of EMGpara as a longitudinal monitoring tool.  Although we have not 
investigated this in the current study, previous investigators (17, 18) have demonstrated 
the measure to be reproducible in pediatric populations. 
The changes observed in EMGpara with age are similar to those previously 
demonstrated using occlusion pressure (19) and are likely to be due to the substantial 
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maturational changes that occur in the respiratory system during childhood.  Decreases 
in airways resistance as a result of lung and airway growth, together with increased 
alveolarisation and vascularisation and ribcage ossification act to decrease the load on 
the respiratory system and hence lead to reductions in the NRD required to maintain 
adequate ventilation.  That these changes are observed when using raw (non-
normalised) EMGpara signals further supports the use of raw EMGpara as a marker of 
NRD.  
It is possible that the increase in skin thickness (and thus muscle-electrode distance) 
occurring with somatic growth may also contribute to the observed decreases in 
EMGpara with increasing age.  Of note, no relationship between age and the magnitude 
of maxEMGpara was observed in the 56 children able to complete maximal inspiratory 
efforts satisfactorily, suggesting that the electrical impedance of the skin and 
subcutaneous tissue is unlikely to be the explanation for falling EMGpara activity with 
increasing age.  Although data regarding the relationship between EMGpara and 
maturational changes in pulmonary function and skin and chest wall tissue properties 
would be valuable, extremely large sample sizes would be required to examine the 
relative contribution of  these variables.  Such studies will only become feasible with the 
development of automated algorithms for EMGpara signal processing and analysis. 
Our study used an age-based prediction equation, thereby accounting for maturational 
changes.  Many of the PICU children were younger than those included in the healthy 
cohort, therefore the reference equation was extrapolated to encompass the lower age 
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range.  We recognise that this approach is not entirely satisfactory,  but has been widely 
used previously in the context of other pulmonary function tests such as spirometry.  
Obtaining EMGpara values from healthy infants would be important in future studies to 
facilitate more accurate comparison between healthy children and patient groups and 
to avoid the need for extrapolation of reference equations.  Similarly, the effect of 
posture on EMGpara has not yet been investigated in children and we recognise the 
limitation of comparing EMGpara values obtained from healthy children in the seated 
position to those from critically ill children measured in the supine posture. 
The importance of obtaining normative data from healthy infants is particularly 
important in light of the subtle differences in activation patterns between the 
diaphragm and the second interspace parasternal intercostal muscles known to be 
present in adults (20).  The presence of a craniocaudal gradient in the onset of 
inspiratory activity in the human parasternal intercostal muscles emphasises the need 
for standardisation of electrode positioning, and the current study utilised the same 
technique as previously published work (8, 9, 14, 18, 21-24).  Recording electrodes were 
placed directly adjacent to the sternal border in the second intercostal space bilaterally, 
with the positive electrode on the right in all patients.  Developmental changes in the 
relative activation of inspiratory muscles have not yet been investigated, neither have 
the relative responses under conditions of elevated load.  There is some disagreement 
within the literature regarding the response of the parasternal intercostal muscles to 
increases in respiratory load:  Roussos et al (25) demonstrated alternating contributions 
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of the diaphragm and intercostal muscles during inspiratory loading tasks, whereas 
Reilly et al showed consistent increases in both muscle groups during incremental 
exercise, with linear increases in parasternal intercostal activity (9).  Detailed clinical and 
laboratory-based studies would be required to fully understand such recruitment 
patterns, taking account of the ongoing anatomical and biomechanical changes 
occurring with growth and development.  
 
Clinical application of EMGpara 
This study has examined the ability of EMGpara to discriminate between healthy 
children and those with respiratory pathology, as well as performing exploratory 
analysis of the predictive ability of EMGpara with respect to extubation outcome and 
the response of the measurement to bronchodilation.   
The major advantages of EMGpara are its applicability to a wide range of clinical 
settings, and across the span of ages encountered in pediatric respiratory care.  The 
children included in this study ranged from newborn to adolescent, and measurements 
were made without any requirement for sedation.  Although some portions of 
recordings were contaminated by movement or speech, these were easily excluded 
from analysis and obtaining at least one minute of uncontaminated recording was 
possible in all of the 137 children studied.  The ability to utilise EMGpara in such a range 
of ages and clinical settings allows a contiguous reference range to be developed and 
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should allow accurate clinical assessment of respiratory status from the intensive care 
unit to the outpatient clinic. 
One clinical area in which the utility of EMGpara requires careful consideration is that of 
neuromuscular disease.  The extent of respiratory compromise is unlikely to be reflected 
by the magnitude of the EMGpara signal in the presence of neuromuscular 
abnormalities.  In such cases, it may be necessary to express the resting signal as a 
percentage of that obtained during a maximal maneuver and provide a measure of the 
load on the respiratory system relative to the capacity of the respiratory muscles.  
Further studies should seek to investigate the relevance of measures of neural drive in 
neuromuscular disease populations.   
The elevated EMGpara observed in both the wheezy and PICU groups when compared 
to healthy controls suggests that a single measure of EMGpara may provide an 
indication of increased respiratory load, and may therefore have potential as a marker 
of disease severity.  EMGpara has previously been shown to relate to disease severity, as 
defined by FEV1, in adults with cystic fibrosis (9) and to reflect variability of airflow 
obstruction in asthmatic adults (13).  In the context of the populations included in the 
current study, levels of EMGpara may be able to guide changes in ventilatory support, or 
aid in determining the severity of wheezing illness.  Previous studies in pediatric cohorts 
have demonstrated EMGpara to be responsive to change in respiratory load induced by 
histamine challenge, with values returning to baseline following bronchodilator 
administration (18, 24).  These investigators, however, expressed EMGpara values 
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relative to the patients’ own baseline values and while this is a robust method for 
assessing intra-individual change, it does not allow comparison to normative values.  
Our study therefore builds on this previous work and brings the technique closer to 
clinical translation. 
The technique could also provide a useful objective assessment tool to assess response 
to bronchodilators (BD).  The absence of objective pulmonary function tests has been 
highlighted as a barrier to optimal treatment in wheezy preschool children(26).  While 
techniques such as Rint and FOT have entered clinical use in some centres, the 
practicalities of obtaining technically acceptable data in young patient populations limit 
the wider uptake of such measures.  EMGpara measurements could be used to support 
clinical judgement when assessing the benefit of BD administration in this population, 
further enhancing diagnosis and helping to guide treatment decisions.  The preschool 
wheeze cohort in this study comprised an unselected group, with a range of disease 
severity and control.  A substantial bronchodilator response was not to be expected in 
all of the subjects studied, and indeed a change in excess of the determined threshold 
was observed in only seven of the twenty subjects.  This may reflect good disease 
control rather than insufficient sensitivity of the technique; indeed previous data 
demonstrate a range of magnitudes of bronchodilator response in asthmatic preschool 
children, quantified by measures of airways resistance(27).  Future studies could 
consider examining EMGpara-based bronchodilator response in a more homogeneous 
group of steroid-naïve preschool children, in whom disease control may be poorer. 
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The PICU cohort was relatively small and clinically heterogeneous, and with only three 
children failing extubation no firm conclusions can be drawn in terms of the utility of the 
technique in guiding extubation timing.  This was undertaken as an exploratory analysis 
only and we do not suggest this to be statistically robust.  Nonetheless, the fact that 
EMGpara-based parameters performed better in this cohort than indices such as the 
RSBI at predicting extubation outcome suggests that EMGpara may have promise in this 
field.  Larger studies would allow age-specific thresholds to be developed to indicate 
likely extubation readiness, facilitating clinical translation of this measure.  Such studies 
would also allow subgroup analysis by clinical presentation, and may reveal differences 
between patients with and without a primary respiratory reason for admission. 
 
Directions for future research 
The promising performance of EMGpara in the current study suggests that the 
technique warrants continued investigation.  Future studies should examine in more 
detail the technical and methodological factors influencing measurement of EMGpara, 
including the effect of posture and individual anthropometric characteristics (with 
particular focus on skin and adipose layer thickness).  Much larger sample sizes should 
be recruited in order to develop robust reference ranges, encompassing the full age 
range from infancy upward.  Future work could also include more detailed clinical and 
physiological characterisation of patients and relating clinical assessment findings to 
EMGpara values, which would allow EMGpara to be more clearly contextualised with 
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respect to the clinical setting.  All of the aforementioned studies will be facilitated by 
development of automated analysis systems. 
 
Conclusion 
Neural respiratory drive, quantified by the electromyogram of the parasternal 
intercostal muscles, is feasible in children and infants across the spectrum of health and 
disease.  EMGpara is raised compared to healthy children in those with elevated 
respiratory load, and is responsive to clinical interventions.  EMGpara represents a 
potential method to assess respiratory status in a population of children for whom 
currently available measures have limited application. 
 
Methods 
The study was granted ethical approval (National Research Ethics Committees London – 
Dulwich and London – Fulham) and conformed to the principles of the Declaration of 
Helsinki.  Parents or caregivers of all participants gave informed written consent.  
Healthy controls 
Healthy children (under the age of 18 years) with no history of cardiorespiratory or 
neurological disease were recruited via friends and family of research staff and students 
and from a database of previous research participants.  Any children exhibiting 
symptoms of an acute viral respiratory tract infection (cough and/or coryza) were 
excluded. 
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Wheezy children 
Children under the age of five years with a physician diagnosis of asthma or persistent 
wheeze were identified from the pediatric respiratory clinics at King’s College Hospital.  
Children with any additional respiratory, cardiac or neurological diagnosis likely to 
impact on respiratory drive were excluded. 
PICU patients 
Patients were recruited from the Pediatric Intensive Care Unit (PICU) at King’s College 
Hospital.  Children who had been mechanically ventilated for greater than 24 hours 
were eligible for inclusion.  Children extubated for palliation were excluded.  
Measurements were performed once the child had been deemed ready for extubation 
by the clinical team.  Extubation failure was defined as reintubation within 48 hours of 
extubation.  Criteria for reintubation were as described previously (28).  Any decision to 
extubate or, where relevant, reintubate was made by the clinical team independent of 
any study measurements.  Clinicians were unaware of the child’s response to the 
spontaneous breathing trial and were blinded to all data acquired during the course of 
the study. 
Measurements 
Parasternal intercostal electromyography 
Self-adhesive silver-silver chloride electrodes (Kendall Arbo, Tyco Healthcare, Neustadt, 
Germany) were placed directly adjacent to the sternal border in the second intercostal 
space bilaterally, with the positive electrode on the right.  A reference electrode was 
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placed on the acromion process of the right scapula or the right olecranon in the case of 
smaller infants.  Prior to electrode placement the skin was prepared using an abrasive 
gel (Nuprep, Weaver and Company, Aurora, CO) and cleaned with an alcohol swab.  The 
EMGpara signals were amplified and band-pass filtered between 10 and 2,000Hz, (1902 
Biomedical Amplifier, Cambridge Electronic Design, Cambridge, UK). 
EMG signals were acquired (Powerlab 16SP, ADInstruments, Sydney, Australia), and 
displayed on a laptop computer running LabChart software (Version 7.2, ADInstruments 
Pty, Colorado Springs, CO) with an analogue to digital sampling rate of 4kHz.  An 
adaptive mains filter was applied to the EMG signals by the acquisition hardware to 
minimise mains frequency interference.  A post-acquisition digital band-pass filter was 
applied between 20Hz and 1,000Hz to isolate the frequencies of interest.  Raw EMG 
signals were converted to root mean square (RMS) using a moving average window of 
50ms.   
Phasic electromyographic activity occurring between QRS complexes was identified and 
peak RMS EMGpara calculated for each breath in which the peak EMG activity was 
uncontaminated by ECG activity.  Mean peak RMS EMGpara per breath (referred to 
throughout as “EMGpara”) was calculated over each stable minute of recording.  In the 
PICU patients, only patient-triggered breaths during MV were analysed.  The final stable 
minute of each subject’s recording period was reported. 
As surface EMG techniques can be affected by a number of factors related to individual 
body composition, particularly subcutaneous adipose tissue, the raw EMGpara signal 
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has often been normalised to that obtained during a maximal inspiratory effort (9, 13, 
14, 22).  This method limits the application of the technique to individuals able to 
reliably comply with such maneuvers, but may also result in greater risk of inaccuracy 
due to the risk of submaximal efforts or contamination of the EMGpara signal through 
recruitment of accessory muscle groups even in those subjects deemed capable of 
performing such maneuvers.  The utility of the raw (non-normalised) EMGpara signal 
has not, to date, been explored.  In this study, we therefore investigated the utility of 
both the raw EMGpara signal (in microvolts) and, where feasible, the normalised value 
(EMGpara expressed as a percentage of maximum, EMGpara%max). 
 
Other measurements 
Respiratory flow was measured in the PICU patients only, using a pneumotachograph 
(4500 series, Hans Rudolph Inc, Kansas City, MO) inserted between the endotracheal 
tube (ETT) connector and the ventilator manifold, and associated differential pressure 
transducer (MP45, Validyne, Northridge, CA) and carrier amplifier (CD280, Validyne, 
Northridge, CA).  Flow was acquired simultaneously with EMGpara (Powerlab 16SP, 
ADInstruments, Sydney, Australia), with an analogue to digital sampling rate of 100Hz.  
Tidal volume (VT) was derived as the digital integral of respiratory flow.  Measures of 
respiratory duty cycle (ratio of inspiratory time to total breath time (Ti:Ttot)) and 
respiratory rate (RR) were also derived from the flow signal. The rapid shallow breathing 
index (RSBI) was also calculated by dividing VT corrected for body weight by respiratory 
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rate (RR) (29).  The ratio of VT corrected for body weight (ml/kg) to EMGpara was also 
used to provide an index of neuroventilatory efficiency (NVE).  As with EMGpara, values 
from the final stable minute of the recording period were reported. 
Protocol 
Protocol – healthy and wheezy children 
Children were seated comfortably in a chair with trunk and legs supported and arms 
resting on thighs.  EMGpara was recorded during ten minutes of steady tidal breathing 
at rest. Portions of the recording during which the child was talking, laughing, moving 
their upper limbs or not fully supported in the chair were annotated and subsequently 
excluded from analysis.  At the end of this period, the child was encouraged to perform 
maximal inspirations to total lung capacity in order to elicit maximal EMGpara activity.  
Verbal encouragement was provided to promote maximal effort from the subject while 
avoiding upper limb and trunk movement.  The intensity of the effort exerted by the 
patient was assessed by the investigator, as was the quality of the EMGpara trace during 
the maneuver.  Three efforts with peak EMGpara activity within 10% of one another 
were required.  If the visual appearance of the EMGpara trace suggested contamination 
from other muscle groups, the effort was deemed technically unacceptable.  The highest 
peak EMGpara value measured during these maneuvers was reported as the maximum 
EMGpara activity (maxEMGpara). 
In a subset of healthy children, repeat measurements of EMGpara were obtained within 
the same testing session to assess repeatability of the measure.  Electrodes were 
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removed following the initial measurement and then skin prepared and electrodes 
reapplied at least one hour later, with measurement of EMGpara performed as 
described above. 
 
Protocol – PICU patients 
Patients were positioned supine during measurements and all had stable heart rate and 
blood pressure.  ETT suction was performed 10-15 minutes prior to study measurements 
being undertaken.  EMGpara, airway pressure and respiratory flow were recorded 
during ten minutes of supported mechanical ventilation (MV) on the settings 
determined by the clinical team.  All patients were ventilated (Evita XL ventilator, 
Dräger, Lübeck, Germany) on spontaneous modes, CPAP plus pressure support or bilevel 
positive airways pressure (BiPAP).  Children were then switched to 5cmH2O CPAP for ten 
minutes, during which EMGpara, airway pressure and flow were measured 
continuously. FiO2 was kept constant throughout.  All ventilator settings and standard 
clinical variables were recorded.  Recordings were annotated to ensure any periods 
incorporating coughing or movement were excluded from analysis. 
Statistical analyses 
The Wilcoxon matched pairs test was used to compare within-subject changes between 
conditions in the preschool wheeze and PICU groups.  Spearman’s correlation 
coefficients were calculated to assess relationships between variables.  Logarithmic 
transformation was applied to the healthy data due to the non-normal distribution of 
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both the data and residuals.  Linear regression analysis was performed to determine a 
prediction equation for normal logEMGpara based on the healthy control subjects’ 
values, with the Wald-Wolfowitz runs test applied to assess for deviation from linearity.  
Predicted logEMGpara was derived from the equation 
Predicted logEMGpara = −0.02347 × age + 0.9332  
EMGpara data from patient groups were log-transformed and then expressed as 
residual standard deviation from the predicted mean logEMGpara value (‘z-score’), 
thereby accounting for differing variability in EMGpara across the age range studied.  
Comparisons between healthy children and the two conditions for each patient group 
were made using the Kruskal-Wallis test with Dunn’s correction for multiple 
comparisons applied.   
Additional exploratory analyses were performed to investigate potential clinical 
applications of the EMGpara technique.  A threshold for a statistically significant 
reduction in EMGpara following bronchodilator was determined in the preschool 
wheeze group from the mean inter-minute coefficient of variation of the EMGpara 
signal multiplied by 1.65 (30).  Receiver operator characteristic (ROC) analysis was used 
in the PICU cohort to evaluate the predictive power of measured variables with respect 
to extubation outcome, using thresholds demonstrating the optimum balance between 
sensitivity and specificity. 
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Sample size calculation 
Due to the exploratory, observational, feasibility nature of the work, no a priori sample 
size calculation was undertaken for this study.  The three study groups represented 
convenience samples. 
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Table 1  
 
Subject characteristics for healthy, wheezy and PICU groups.  Data are shown as median 
(IQR). 
 
Healthy subjects 
(n=92) 
Preschool wheeze patients 
(n=20) 
PICU patients 
(n=25) 
Age (years) 
9.51 
(5.14 – 13.99) 
3.70 
(2.23 – 4.43) 
1.00 
(0.40 – 5.80) 
Sex (M : F) 35 : 57 12 : 8 12 : 13 
Weight (kg) 
32.40 
(20.79 – 54.25) 
15.03 
(13.46 – 16.40)  
9.3 
(5.25 – 26.00) 
Height (m) 
1.43 
(1.13 – 1.64) 
0.98 
(0.91 – 1.01) 
Data not available 
BMI (kg.m
-2
) 
17.05 
(15.84 – 21.54) 
15.94 
(15.28 – 17.03) 
Data not available 
BMI-for-age percentile 
64.4 
(40.2 – 85.7) 
51.5 
(22.2 – 86.3) 
Data not available 
Ethnicity (n(%)) 
White:  58 (63.0) 
Black:  22 (23.9) 
Asian:  6 (6.5) 
Other:  6 (6.5) 
White:  13 (65.0) 
Black:  4 (20.0) 
Other:  3 (15.0) 
White:  14 (56.0) 
Black:  3 (12.0) 
Asian:  8 (32.0) Ac
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Table 2   
 
Clinical characteristics of 25 PICU children.  Data are shown as median (IQR). 
 
Peak inspiratory pressure (cmH2O) 
14 
(12 – 15) 
Positive end expiratory pressure 
(cmH2O) 
5 
(5 – 6) 
Duration of mechanical ventilation 
(days) 
5 
(2 – 7) 
Fraction of inspired oxygen 
0.30  
(0.26 – 0.35) 
Primary reason for admission 
Respiratory failure (n=7) 
Liver transplant (n=8) 
Other abdominal surgery (n=4) 
Neurological/neurosurgical condition (n=5) 
Abdominal sepsis (n=1) 
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Table 3  
 
Comparison of respiratory variables during mechanical ventilation (MV) and 
spontaneous breathing on continuous positive airways pressure (CPAP) in 25 PICU 
patients.  Data are presented as median (IQR).  EMGpara: parasternal intercostal 
electromyogram; NVE: neuroventilatory efficiency; RR: respiratory rate; Ti:Ttot: 
respiratory duty cycle. 
 
 MV CPAP p value 
Change from MV to 
CPAP (%) 
EMGpara (µV) 
10.4 
(7.4 – 14.5) 
12.7 
(9.9 – 17.9) 
0.0001 
16.7 
(2.1 – 34.0) 
NVE (ml/kg/µV) 
0.77 
(0.46 – 1.11) 
0.57 
(0.40 – 0.79) 
0.0001 
-18.4 
(-32.0 – 0.1) 
RR 
35 
(24 – 48) 
35 
(27 – 47)  
0.178 
2.7 
(-5.2 – 18.6) 
Tidal volume (ml/kg) 
7.0 
(6.6 – 9.5) 
7.5 
(6.2 – 9.7) 
0.628 
-2.0 
(-11.9 – 11.5) 
Ti:Ttot 
0.37 
(0.34 – 0.41) 
0.39 
(0.35 – 0.45) 
0.279 
3.3 
(-3.5 – 10.0) 
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Table 4  
 
Maximum sensitivity and specificity of individual variables in predicting extubation failure, with 
areas under the receiver operating characteristics curve for 25 PICU patients.  NVE: 
neuroventilatory efficiency; EMGpara: parasternal intercostal electromyogram; VT: tidal volume; 
RSBI: rapid shallow breathing index; Ti:Ttot: respiratory duty cycle; RR: respiratory rate. 
 
Parameter Threshold Sensitivity/specificity 
Area under 
ROC curve 
NVE (CPAP) <0.43ml/kg/µV 100/81.8 0.947 
NVE (MV) <0.57ml/kg/µV 77.3/100 0.917 
EMGpara (CPAP) >14.8µV 100/72.7 0.879 
EMGpara (MV) >14.0µV 81.8/100 0.879 
VT (CPAP) <6.4ml/kg 100.72/7 0.742 
ΔNVE (MV to CPAP) >-18.4% 100/59.1 0.697 
RSBI (MV) >3.84 100/50.0 0.697 
Ti:Ttot (CPAP) >0.34 86.4/66.7 0.682 
RSBI (CPAP) >4.34 100/54.6 0.682 
VT (MV) <7.21ml/kg 100/54.6 0.667 
RR (CPAP) >40bpm 66.7/72.7 0.606 
Ti:Ttot (MV) >0.40 100/36.4 0.591 
RR (MV) >41bpm 66.7/68.2 0.576 
ΔEMGpara (MV to 
CPAP) 
<9.7% 66.7/63.6 0.546 
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Figure legends 
 
Figure 1   Representative traces of EMGpara before (a) and after (b) bronchodilator 
administration 
Figure 2  Relationships between EMGpara and age (a), height (b) and weight (c) in 92 
healthy children 
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Figure 1 
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